Strong Revenue Growth
GXO delivered a revenue of $3 billion for Q1 2025, which represents a 21% year-over-year increase.
Healthcare Sector Expansion
GXO finalized a landmark $2.5 billion deal with the U.K. National Health Services supply chain and signed contracts with Siemens Healthineers, showcasing significant progress in the healthcare vertical.
Sales Pipeline and New Business Wins
New business wins in the quarter were $228 million, and the sales pipeline (excluding Wincanton) reached a three-year high of $2.5 billion.
AI and Technology Advancements
GXO implemented AI modules for proactive replenishment, SKU dimensioning, and order routing, which began delivering cost savings in Q1 2025.
Operating Return on Invested Capital
Operating return on invested capital increased to 45%, rising 12 percentage points from Q1 2024.